|
Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy
RECRUITINGSponsored by Pr. Nicolas GIRERD
Actively Recruiting
SponsorPr. Nicolas GIRERD
Started2023-05-06
Est. completion2024-05-06
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06256913
Summary
Hypertrophic cardiomyopathy is a pathology with a highly variable course, ranging from patients who are asymptomatic throughout their lives to those who experience sudden death and/or terminal heart failure. The main objective is to develop and validate an algorithm (constructed through supervised learning) using cardiac imaging data to predict the risk of cardiovascular events in sarcomeric hypertrophic cardiomyopathy.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age \>18 * Patients with confirmed sarcomeric hypertrophic cardiomyopathy Exclusion Criteria: * Echocardiographic data not allowing deep analysis (technical default, bad echogenicity of the patient) * Other causes of left ventricular hypertrophy that may hamper the diagnosis (p.e. aortic or sub-aortic stenosis, severe renal insufficiency, hypertension). * History of ischemic heart disease or associated myocarditis * Opposition of the patient to the use of his/her data
Conditions2
Heart DiseaseHypertrophic Cardiomyopathy
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorPr. Nicolas GIRERD
Started2023-05-06
Est. completion2024-05-06
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06256913